Xiang G - Search Results

1

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.

Qu X, Yang C, Zhang J, Ding N, Lu Y, Huang L, Xiang G. Qu X, et al. Among authors: xiang g. J Drug Target. 2010 Jun;18(5):351-61. doi: 10.3109/10611860903450049. J Drug Target. 2010. PMID: 20001219

2

[Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].

Zhang Q, Xiang GY, Long N, Lin JL, Zeng FB. Zhang Q, et al. Yao Xue Xue Bao. 2005 Nov;40(11):1046-50. Yao Xue Xue Bao. 2005. PMID: 16499093 Chinese.

3

Increase of doxorubicin sensitivity for folate receptor positive cells when given as the prodrug N-(phenylacetyl) doxorubicin in combination with folate-conjugated PGA.

Zhang Q, Xiang G, Zhang Y, Yang K, Fan W, Lin J, Zeng F, Wu J. Zhang Q, et al. Among authors: xiang g. J Pharm Sci. 2006 Oct;95(10):2266-75. doi: 10.1002/jps.20714. J Pharm Sci. 2006. PMID: 16883559

4

Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.

Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. Xiang G, et al. Int J Pharm. 2008 May 22;356(1-2):29-36. doi: 10.1016/j.ijpharm.2007.12.030. Epub 2007 Dec 28. Int J Pharm. 2008. PMID: 18258394 Free PMC article.

5

Folate receptor-targeted quantum dot liposomes as fluorescence probes.

Yang C, Ding N, Xu Y, Qu X, Zhang J, Zhao C, Hong L, Lu Y, Xiang G. Yang C, et al. Among authors: xiang g. J Drug Target. 2009 Aug;17(7):502-11. doi: 10.1080/10611860903013248. J Drug Target. 2009. PMID: 19489689

6

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.

Ding N, Lu Y, Lee RJ, Yang C, Huang L, Liu J, Xiang G. Ding N, et al. Among authors: xiang g. Int J Nanomedicine. 2011;6:2513-20. doi: 10.2147/IJN.S23934. Epub 2011 Oct 20. Int J Nanomedicine. 2011. PMID: 22072885 Free PMC article.

7

Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.

Shang X, Ding N, Xiang G. Shang X, et al. Among authors: xiang g. Eur J Med Chem. 2012 Feb;48:305-12. doi: 10.1016/j.ejmech.2011.12.032. Epub 2011 Dec 28. Eur J Med Chem. 2012. PMID: 22226547

8

Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.

Lu Y, Ding N, Yang C, Huang L, Liu J, Xiang G. Lu Y, et al. Among authors: xiang g. J Liposome Res. 2012 Jun;22(2):110-9. doi: 10.3109/08982104.2011.627514. Epub 2012 Feb 28. J Liposome Res. 2012. PMID: 22372871

9

Determination of imatinib mesylate and related compounds by field amplified sample stacking with large volume sample injection capillary electrophoresis.

Li J, Huang Y, Huang L, Ye L, Zhou Z, Xiang G, Xu L. Li J, et al. Among authors: xiang g. J Pharm Biomed Anal. 2012 Nov;70:26-31. doi: 10.1016/j.jpba.2012.05.010. Epub 2012 May 14. J Pharm Biomed Anal. 2012. PMID: 22677653

10

Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.

Ye P, Zhang W, Yang T, Lu Y, Lu M, Gai Y, Ma X, Xiang G. Ye P, et al. Among authors: xiang g. Int J Nanomedicine. 2014 May 7;9:2167-78. doi: 10.2147/IJN.S60178. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24855354 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,127 results

Search Page

Filters